Stock Events

Guangzhou Baiyunshan Pharmaceutical Company Limited (874.HK) Q2 2026 Earnings

Name: Guangzhou Baiyunshan Pharmaceutical Company Limited (874.HK) Q2 2026 Earnings
Start: 2026-04-27
End: 2026-04-27

27AprConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

0.47

0.73

0.99

1.25

Expected EPS

N/A

Actual EPS

1.2455756425419

Surprise EPS

1.25

Surprise Percent

+∞%

Guangzhou Baiyunshan Pharmaceutical Company Limited (874.HK) has reported earnings of 1.2455756425419 per share for Q2 2026.

Get the Stock Events App